期刊文献+

246例次深静脉置管急诊血液透析治疗的安全性分析 被引量:18

The safety analysis of 246 cases emergent hemodialysis with profound venous catheters
下载PDF
导出
摘要 目的 深静脉置管急诊血液透析是肾脏替代治疗的一种有效手段。本文通过对不同深静脉置管部位出现的并发症进行分析,以寻找最佳的深静脉置管急诊血液透析的方式。方法 本文分析了1993年1月至2000年6月期间,因急慢性肾功能衰竭行深静脉置管急诊血液透析治疗的住院患者。置管部位为股静脉、锁骨下静脉和颈内静脉。肝素封管方法为大剂量常规肝素一次性封管和小剂量肝素多次封管两种。结果 219例患者接受了246例次深静脉置管急诊血液透析治疗,平均置管保留时间为19.6天,合并症发生率为28.0%。股静脉置管平均保留时间为(16.89±8.11)天,合并症发生率为30.4%;锁骨下静脉置管平均保留时间为(19.85±12.10)天,合并症的发生率为38.9%;颈内静脉置管平均保留时间为(25.21±10.95)天,合并症的发生率为10.2%,与股静脉或锁骨下静脉置管相比有显著性差异(P<0.05)。结论 颈内静脉置管行急诊血液透析置管保留时间最长,合并症发生率最低,最为安全可靠,应为急诊血液透析治疗首选的临时血普通路。股静脉置管方法操作方便,相对安全,但影响患者活动。锁骨下静脉置管可出现较为严重的并发症,危险性较大,不建议作为急诊血液透析治疗时的临时血管通路。 Objective To analysis the vascular catheter - related complications in retrospective way and to find the best way of deep venous catheterization for emergent hemodialysis( HD).Methods The in - hospital patients received deep venous catheterization for emergent HD because of acute or chronic renal failure from Jan 1993 to Jun 2000.Catheter locations were femoral,subclavian and internal jugular vein.Heparin was used for sealing catheters,with only once during inter - dialysis session or twice every day.Results There were 219 patients received 246 treatments with deep vein catheterization for the purpose of emergent HD.The average period of maintaining catheters was 19.6 days.The total incidence of complications was 28.0%.The average period of catheters maintaining for internal jugular vein was longer than that of femoral and subclavian vein (25.21 +10.95) days,(16.89+8.11) days,P<0.057(25.21 + 10.95) days,(19.85+ 12.10) days,P< 0.05,respectively.The incidence of catheter - related complications of internal jugular vein (10.2%) was lower than that of femoral (30.4%,P < 0.05) and subclavian vein (38.9% ,P < 0.05).Conclusion Internal jugular vein catheterization is the first choice of temporary access for emergent HD.
作者 孙阳 李学旺
机构地区 中国医学科学院
出处 《中国血液净化》 2002年第10期9-11,共3页 Chinese Journal of Blood Purification
关键词 血液透析 插管 Hemodialysis catheterization
  • 相关文献

参考文献5

  • 1[1]Kairaitis LK,Gottlieb. Outcome and complications of temporary hemodialysis catheters. Nephrol Dial Transplant,1999,14:1710-1714
  • 2[2]Almirall J,Gonzalez J,Brown EA,et al. Infection of hemodialysis catheters:Incidence and mechanisms. Am J Nephrol,1989,9:454-459
  • 3[3]Oliver MJ, Callery SM, Thorpe KE, et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int,2000,58:2543-2545
  • 4[4]De Moor B, Vanholder R, Ringoir S. Subclavian vein hemodialysis catheters: advantages and disadvantages. Artif Organs, 1994,18(4):293-297
  • 5王玉柱,于仲元,朱军,蔡美顺,李月红,苏华,孙翌,谈一意,赵慧萍.股静脉与颈内静脉留置双腔导管在血液透析中的应用[J].中国血液净化,2002,1(2):39-42. 被引量:29

二级参考文献19

  • 1马骏,郝传明,林善锬.双(三)腔留置导管在长期血透中的应用[J].中华肾脏病杂志,1995,11(2):66-68. 被引量:22
  • 2[1]Fan PY, Schwab SJ.Vascular access: concepts for the 1990's.J Am Soc Nephrol, 1992, 3:1 - 11
  • 3[2]Windus D Permanent vascular access: a nephrologists view. Am J kidney Dis, 1993, 21:457 - 471
  • 4[3]Schwab SJ, Bullef GL, Mc Cann RL, et al. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis, 1988, 11:166 - 169
  • 5[4]Tesio F, De Baz H, Panarello G, et al. Double catheterization of the internal jugular vein for hemodialysis: indications, techniques,and clinical results. Artif Organs, 1994,18:301 - 304
  • 6[5]Bradley M, Glenn M., William F. Vascular Access. In: The kidney. 6th ed. Edited by Barry M. Brenner, 2001,2373 - 2380
  • 7[6]Schwab SJ, Quarles LD, Middleton JP, et al. Hemodialysis associated subclavian vein stenosis. Kidney Int, 1988, 33:1156 - 1159
  • 8[7]Daugirdas JT. The post: pre plasma urea nitrogen ratio to estimate Kt/V and NPCR: Mathematical Modeling.Int J Artif Organ,1989, 12:411 - 414
  • 9[8]Schwab SJ, Besarab A, Beathard G, et al. NKF- DOQI clinical practice guidelines for vascular access. National kidney Foundation- Dialysis Outcomes Quality Initiative. Am J Kidney Dis, 1997, 30(suppl 3): S150 - S191
  • 10[9]Besarab A, Adams M, Amatucci S, et al. Unraveling the realities of vascular access: the Network 11 experience. Adv Ren Replace Ther, 2000, 7(4 suppl 1): S65 - 70

共引文献28

同被引文献66

引证文献18

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部